Kadant (NYSE:KAI – Get Free Report) is scheduled to announce its earnings results after the market closes on Tuesday, April 30th. Analysts expect the company to announce earnings of $1.96 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
Kadant (NYSE:KAI – Get Free Report) last issued its quarterly earnings results on Wednesday, February 14th. The industrial products company reported $2.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.10 by $0.31. The firm had revenue of $238.68 million for the quarter, compared to the consensus estimate of $227.54 million. Kadant had a net margin of 12.12% and a return on equity of 16.20%. On average, analysts expect Kadant to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.
Kadant Stock Up 1.0 %
Shares of NYSE KAI opened at $282.37 on Friday. The company has a market capitalization of $3.32 billion, a P/E ratio of 28.52 and a beta of 1.27. Kadant has a 52-week low of $183.49 and a 52-week high of $354.02. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.34 and a current ratio of 2.05. The company’s 50 day moving average price is $312.84 and its 200-day moving average price is $281.37.
Kadant Increases Dividend
Insider Buying and Selling at Kadant
In other Kadant news, Director Jonathan W. Painter sold 7,000 shares of the business’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $330.25, for a total transaction of $2,311,750.00. Following the completion of the sale, the director now owns 7,615 shares in the company, valued at approximately $2,514,853.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Stacy D. Krause sold 700 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $327.00, for a total value of $228,900.00. Following the completion of the sale, the senior vice president now owns 881 shares in the company, valued at approximately $288,087. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jonathan W. Painter sold 7,000 shares of the company’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $330.25, for a total transaction of $2,311,750.00. Following the completion of the sale, the director now owns 7,615 shares of the company’s stock, valued at approximately $2,514,853.75. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,798 shares of company stock worth $2,899,004. 1.40% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the stock. StockNews.com lowered shares of Kadant from a “buy” rating to a “hold” rating in a research note on Thursday, January 4th. Barrington Research reiterated an “outperform” rating and issued a $300.00 price objective on shares of Kadant in a research note on Wednesday, February 14th.
Read Our Latest Research Report on Kadant
Kadant Company Profile
Kadant Inc supplies technologies and engineered systems worldwide. It operates in three segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment develops, manufactures, and markets fluid-handling systems and equipment, such as rotary joints, syphons, turbulator bars, expansion joints, and engineered steam and condensate systems; and doctoring, cleaning, and filtration systems and related consumables consisting of doctor systems and holders, doctor blades, cleaning shower and fabric-conditioning systems, forming systems and wear surfaces, and water-filtration systems.
Read More
- Five stocks we like better than Kadant
- How to Effectively Use the MarketBeat Ratings Screener
- MarketBeat Week in Review – 4/22 – 4/26
- How to Capture the Benefits of Dividend Increases
- 3 Stocks Leading the U.S. Agriculture Comeback
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Kadant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadant and related companies with MarketBeat.com's FREE daily email newsletter.